Michael Shalmi
Business
Orexo
Sweden
Biography
Board member since 2010 M.D., MBA. Other appointments: Managing Director and Head of Large Investments, Novo Holdings A/S. Previous appointments: 15 years at Novo Nordisk; V.P. International Marketing, Corporate VP Haemostasis and Chief Medical Officer BioPharm, V.P. of Haematology Business Unit, V.P. BioPharm Business Unit, and Corporate V.P. Global Development, Clinical Operations Management at Novo Nordisk HQ. Does not hold any shares in Orexo, as of December 31 2016.
Research Interest
Interested in business
